Korea OKs Sanofi’s monoclonal antibody injection against RSV for infants
Sanofi Korea said it received marketing approval from the Ministry of Food and Drug Safety for Beyfortus, a monoclonal antibody injection designed to prevent respiratory syncytial virus (RSV) in infants. RSV is a major cause of respiratory illness in young …